| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_673f447fc584b6a123cf4d63fdaeeb8f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| filingDate |
2017-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ceb9b31529f95d058550b811587a3b5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b918d99af1059fb24f0adb28467ab2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eca007d8655d4456c92d1194ae410d3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6c6f8c604294b156e2d31d52183cbcd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_314e3dc1c71f14490e3c49961d3c92c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d4db95c81707423874e93b287b6cfcd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84399bb19bcc3f7f7ae09c6ec145e811
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72dd821eb5bfe85fe3c63f0081e1e8db |
| publicationDate |
2017-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017148363-A1 |
| titleOfInvention |
Uses of alginic acid sulfate in preparation of drugs and health care products for preventing and treating diseases caused by human papilloma viruses |
| abstract |
Uses of alginic acid sulfate in the preparation of drugs and health care products for preventing and treating diseases caused by human papilloma viruses. The alginic acid sulfate is a sulfuric acid polysaccharide compound formed by introducing sulfate groups on C2 and C3 sites of alginic acid. In the alginic acid sulfate, the weight-average molecular weight is 6 kDa to 100 kDa, the content of ploymannuronic acid is 5% to 95%, the content f polyguluronic acid is 5% to 95%，and the substitution degree of sulfate radicals is 5% to 15%. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022021315-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114053297-A |
| priorityDate |
2016-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |